Rob Sprawson is Partner and Chief Financial Officer for CIC. He has more than 20 years of professional and commercial experience providing strategic, financial and corporate finance advice to Boards and shareholders, especially in the pharmaceutical, biotechnology, technology and technology consulting industries.
His previous roles have included Chief Financial Officer of Altacor Limited, an ophthalmic specialty pharmaceutical company, Chief Financial and Commercial Officer of Warwick Ventures Limited, the Technology Transfer Office of the University of Warwick, Chief Financial Officer of an AIM listed drug development company and Senior Manager, Corporate Finance at PricewaterhouseCoopers. Rob also acted as a consultant to Lumora Limited, a molecular diagnostics company spun-out from the University of Cambridge, from January 2010 until the sale of the business to Roche and ERBA Diagnostics Mannheim in 2015.
He is a Fellow of the Institute of Chartered Accountants in England and Wales and holds a BA (Hons) in Accounting and Financial Analysis from Newcastle University.